188 related articles for article (PubMed ID: 37482300)
1. Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study.
Miao Z; Zeng FF; Tian Y; Xiao C; Yan Y; Jiang Z; Fu Y; Chen YM; Zheng JS
Am J Clin Nutr; 2023 Sep; 118(3):637-645. PubMed ID: 37482300
[TBL] [Abstract][Full Text] [Related]
2. Pure omega 3 polyunsaturated fatty acids (EPA, DPA or DHA) are associated with increased plasma levels of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) in a short-term study in women.
Liu G; Gibson RA; Callahan D; Guo XF; Li D; Sinclair AJ
Food Funct; 2020 Mar; 11(3):2058-2066. PubMed ID: 32142084
[TBL] [Abstract][Full Text] [Related]
3. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.
Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X
J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682
[TBL] [Abstract][Full Text] [Related]
4. Furan fatty acids - Beneficial or harmful to health?
Xu L; Sinclair AJ; Faiza M; Li D; Han X; Yin H; Wang Y
Prog Lipid Res; 2017 Oct; 68():119-137. PubMed ID: 29051014
[TBL] [Abstract][Full Text] [Related]
5. CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome.
Lankinen MA; Hanhineva K; Kolehmainen M; Lehtonen M; Auriola S; Mykkänen H; Poutanen K; Schwab U; Uusitupa M
PLoS One; 2015; 10(4):e0124379. PubMed ID: 25874636
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial.
Zheng JS; Lin M; Imamura F; Cai W; Wang L; Feng JP; Ruan Y; Tang J; Wang F; Yang H; Li D
Sci Rep; 2016 Jul; 6():29522. PubMed ID: 27404516
[TBL] [Abstract][Full Text] [Related]
8. Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts.
Ong KL; Marklund M; Huang L; Rye KA; Hui N; Pan XF; Rebholz CM; Kim H; Steffen LM; van Westing AC; Geleijnse JM; Hoogeveen EK; Chen YY; Chien KL; Fretts AM; Lemaitre RN; Imamura F; Forouhi NG; Wareham NJ; Birukov A; Jäger S; Kuxhaus O; Schulze MB; de Mello VD; Tuomilehto J; Uusitupa M; Lindström J; Tintle N; Harris WS; Yamasaki K; Hirakawa Y; Ninomiya T; Tanaka T; Ferrucci L; Bandinelli S; Virtanen JK; Voutilainen A; Jayasena T; Thalamuthu A; Poljak A; Bustamante S; Sachdev PS; Senn MK; Rich SS; Tsai MY; Wood AC; Laakso M; Lankinen M; Yang X; Sun L; Li H; Lin X; Nowak C; Ärnlöv J; Risérus U; Lind L; Le Goff M; Samieri C; Helmer C; Qian F; Micha R; Tin A; Köttgen A; de Boer IH; Siscovick DS; Mozaffarian D; Wu JH
BMJ; 2023 Jan; 380():e072909. PubMed ID: 36653033
[TBL] [Abstract][Full Text] [Related]
9. Serum omega-3 polyunsaturated fatty acids and risk of incident type 2 diabetes in men: the Kuopio Ischemic Heart Disease Risk Factor study.
Virtanen JK; Mursu J; Voutilainen S; Uusitupa M; Tuomainen TP
Diabetes Care; 2014; 37(1):189-96. PubMed ID: 24026545
[TBL] [Abstract][Full Text] [Related]
10. Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women.
Yi J; Jin H; Zhang R; Zhang S; Chen P; Yu X; Zhang X
J Endocrinol Invest; 2018 Jun; 41(6):663-670. PubMed ID: 29151239
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte n-6 Polyunsaturated Fatty Acids, Gut Microbiota, and Incident Type 2 Diabetes: A Prospective Cohort Study.
Miao Z; Lin JS; Mao Y; Chen GD; Zeng FF; Dong HL; Jiang Z; Wang J; Xiao C; Shuai M; Gou W; Fu Y; Imamura F; Chen YM; Zheng JS
Diabetes Care; 2020 Oct; 43(10):2435-2443. PubMed ID: 32723842
[TBL] [Abstract][Full Text] [Related]
12. Changes of urine metabolites in response to n-3 fatty acid supplements and their correlation with metabolic risk factors in patients with type 2 diabetes.
Ruan Y; Zheng J; Ren Y; Tang J; Li J; Li D
Food Funct; 2019 May; 10(5):2471-2479. PubMed ID: 30977496
[TBL] [Abstract][Full Text] [Related]
13. Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies.
Wu JHY; Marklund M; Imamura F; Tintle N; Ardisson Korat AV; de Goede J; Zhou X; Yang WS; de Oliveira Otto MC; Kröger J; Qureshi W; Virtanen JK; Bassett JK; Frazier-Wood AC; Lankinen M; Murphy RA; Rajaobelina K; Del Gobbo LC; Forouhi NG; Luben R; Khaw KT; Wareham N; Kalsbeek A; Veenstra J; Luo J; Hu FB; Lin HJ; Siscovick DS; Boeing H; Chen TA; Steffen B; Steffen LM; Hodge A; Eriksdottir G; Smith AV; Gudnason V; Harris TB; Brouwer IA; Berr C; Helmer C; Samieri C; Laakso M; Tsai MY; Giles GG; Nurmi T; Wagenknecht L; Schulze MB; Lemaitre RN; Chien KL; Soedamah-Muthu SS; Geleijnse JM; Sun Q; Harris WS; Lind L; Ärnlöv J; Riserus U; Micha R; Mozaffarian D;
Lancet Diabetes Endocrinol; 2017 Dec; 5(12):965-974. PubMed ID: 29032079
[TBL] [Abstract][Full Text] [Related]
14. Association of n-3 polyunsaturated fatty acids and inflammatory indicators with renal function decline in type 2 diabetes.
Chung HF; Long KZ; Hsu CC; Al Mamun A; Jhang HR; Shin SJ; Hwang SJ; Huang MC
Clin Nutr; 2015 Apr; 34(2):229-34. PubMed ID: 24721145
[TBL] [Abstract][Full Text] [Related]
15. Association of erythrocyte n-3 polyunsaturated fatty acids with incident type 2 diabetes in a Chinese population.
Zheng JS; Lin JS; Dong HL; Zeng FF; Li D; Song Y; Chen YM
Clin Nutr; 2019 Oct; 38(5):2195-2201. PubMed ID: 30309708
[TBL] [Abstract][Full Text] [Related]
16. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis.
Mohan H; Brandt SL; Kim JH; Wong F; Lai M; Prentice KJ; Al Rijjal D; Magomedova L; Batchuluun B; Burdett E; Bhattacharjee A; Cummins CL; Belsham DD; Cox B; Liu Y; Wheeler MB
Diabetes Obes Metab; 2019 Jan; 21(1):61-72. PubMed ID: 30062833
[TBL] [Abstract][Full Text] [Related]
17. Furan fatty acid metabolite in newborns predicts risk of asthma.
Gürdeniz G; Kim M; Brustad N; Ernst M; Russo F; Stokholm J; Bønnelykke K; Hougaard D; Rasmussen M; Cohen A; Chawes B
Allergy; 2023 Feb; 78(2):429-438. PubMed ID: 36254396
[TBL] [Abstract][Full Text] [Related]
18. Circulating polyunsaturated fatty acids, fish oil supplementation, and risk of incident dementia: a prospective cohort study of 440,750 participants.
He Y; Huang SY; Wang HF; Zhang W; Deng YT; Zhang YR; Dong Q; Feng JF; Cheng W; Yu JT
Geroscience; 2023 Jun; 45(3):1997-2009. PubMed ID: 37046127
[TBL] [Abstract][Full Text] [Related]
19. The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study.
Dai L; Massy ZA; Stenvinkel P; Chesnaye NC; Larabi IA; Alvarez JC; Caskey FJ; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Wanner C; Jager KJ; Dekker FW; Evenepoel P; Evans M;
Am J Clin Nutr; 2022 Dec; 116(6):1842-1851. PubMed ID: 36166845
[TBL] [Abstract][Full Text] [Related]
20. Nontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trial.
Hanhineva K; Lankinen MA; Pedret A; Schwab U; Kolehmainen M; Paananen J; de Mello V; Sola R; Lehtonen M; Poutanen K; Uusitupa M; Mykkänen H
J Nutr; 2015 Jan; 145(1):7-17. PubMed ID: 25527657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
